Homologous recombination

Lore & Background

In the early 1900s, William Bateson and Reginald Punnett found an exception to Mendel's principle of independent assortment, showing that certain genes can be inherited together. In 1911, Thomas Hunt Morgan suggested that 'crossovers' can occur between linked genes. Two decades later, Barbara McClintock and Harriet Creighton demonstrated that chromosomal crossover occurs during meiosis, and Curt Stern showed crossing over could occur in germline cells (meiosis), not somatic cells. In 1947, Joshua Lederberg showed bacteria are capable of genetic recombination, establishing E. coli as a model organism. In 1964, Robin Holliday proposed a model for recombination in meiosis introducing Holliday junctions.

Reader's Guide

Homologous recombination is fundamental to life, enabling accurate repair of double-strand breaks and generating genetic diversity during meiosis. Its conservation across all domains of life and viruses underscores its ancient origin. The discovery of genes for homologous recombination in protists suggests it emerged early in eukaryotic evolution. Dysfunction of the proteins facilitating homologous recombination is strongly associated with increased susceptibility to several types of cancer, making them topics of active research. The technique of gene targeting, which uses homologous recombination to introduce genetic changes into target organisms, earned Mario Capecchi, Martin Evans, and Oliver Smithies the 2007 Nobel Prize in Physiology or Medicine. The highly conserved mechanisms underlying the DSB repair model, including uniform homologous integration of transformed DNA, were first shown in plasmid experiments by Orr-Weaver, Szostak, and Rothstein. Research on plasmid-induced DSB using γ-irradiation in the 1970s-1980s led to later experiments using endonucleases to cut chromosomes for genetic engineering of mammalian cells.

Did You Know?

• Homologous recombination is used in horizontal gene transfer to exchange genetic material between different strains and species of bacteria and viruses, and is the primary mechanism for the spread of antibiotic resistanc
• The absence of a recombination hotspot between two genes on the same chromosome often means those genes will be inherited in equal proportion, representing linkage greater than expected from independent assortment.
• Homologous recombination repairs DNA before the cell enters mitosis, occurring during and shortly after DNA replication in the S and G2 phases of the cell cycle when sister chromatids are available.
• The proteins that facilitate homologous recombination are topics of active research because their dysfunction has been strongly associated with increased susceptibility to several types of cancer.

Molecular Mechanics of the Process

Homologous recombination follows a remarkably consistent sequence of molecular events across organisms, even though the specific details vary between cell types. When a double-strand break occurs in DNA, the first critical step is resection, in which short segments flanking the 5' ends of the break are trimmed away. This creates an overhanging 3' single-stranded tail. That tail then performs what is called strand invasion, penetrating a nearby intact homologous DNA molecule to find a complementary sequence. From this point, the process diverges into two principal routes: the double-strand break repair (DSBR) pathway and the synthesis-dependent strand annealing (SDSA) pathway. In the context of DNA repair, the outcome typically takes the form of a non-crossover product, meaning the damaged strand is essentially restored to its original configuration without swapping genetic material with its partner. This fidelity is crucial, as it ensures that the cell's genetic blueprint remains intact after the repair event.

Roles in Repair, Reproduction, and Evolution

Homologous recombination serves multiple vital functions across the tree of life. In its most immediate role, it acts as a precision repair mechanism for double-strand breaks, the harmful lesions in which both strands of the DNA helix are severed. Cells rely on this homologous recombinational repair to restore genomic integrity, and failure to do so can trigger large-scale chromosomal rearrangements that contribute to cancer. Beyond repair, the process is central to meiosis, the specialized cell division that produces gametes such as sperm, eggs, pollen, ovules, and spores. During meiosis, recombination shuffles genetic material between homologous chromosomes, generating novel combinations of alleles in offspring and thereby fueling the genetic variation upon which natural selection acts. In prokaryotes and viruses, homologous recombination underpins horizontal gene transfer, the exchange of genetic material across species boundaries. This mechanism is particularly significant as the primary route through which antibiotic resistance spreads among bacterial populations. The fact that homologous recombination is conserved across all three domains of life and in both DNA and RNA viruses underscores its near-universal importance.

A Century of Discovery

The story of homologous recombination stretches back to the early 1900s, when William Bateson and Reginald Punnett identified that certain traits are inherited together rather than independently, contradicting a strict reading of Mendel's principles. Thomas Hunt Morgan, building on observations of linked traits occasionally separating, proposed in 1911 that physical crossovers between chromosomes could explain the phenomenon. Two decades later, Barbara McClintock and Harriet Creighton provided direct evidence that such crossovers occur during meiosis, while Curt Stern demonstrated that recombination also takes place in somatic cells dividing by mitosis. Joshua Lederberg's 1947 revelation that bacteria undergo genetic recombination, challenging the assumption that they reproduce solely by binary fission, established E. coli as a genetics workhorse and earned him the 1958 Nobel Prize. Robin Holliday's 1964 model introduced the concept of Holliday junctions, and Jack Szostak's 1983 DSBR pathway model later resolved gaps in the earlier framework. Subsequent work by James Haber, Patrick Sung, Stephen Kowalczykowski, and others identified the proteins that execute each step of the process.

Medical Impact and Biotechnological Applications

The proteins that carry out homologous recombination have become focal points in cancer research, because their dysfunction is strongly linked to heightened susceptibility to multiple cancer types. This clinical relevance has driven intense investigation into the molecular machinery of recombination. On the applied side, homologous recombination is the engine behind gene targeting, a technique for introducing precise genetic modifications into organisms. Mario Capecchi, Martin Evans, and Oliver Smithies received the 2007 Nobel Prize in Physiology or Medicine for developing this approach, with Capecchi and Smithies independently applying it to mouse embryonic stem cells. However, the foundational observation that double-strand breaks trigger uniform homologous integration of foreign DNA was first demonstrated in plasmid experiments by Orr-Weaver, Szostak, and Rothstein. Their work with γ-irradiation in the 1970s and 1980s paved the way for later genetic engineering strategies using site-specific endonucleases such as I-SceI to cut chromosomes in mammalian cells, where nonhomologous recombination is more prevalent than in yeast. These advances continue to underpin modern gene therapy and transgenic organism development.